Zobrazeno 1 - 10
of 418
pro vyhledávání: '"Flem E"'
Autor:
Flem E; MRL, Medical Affairs, Merck & Co., Inc, Rahway, NJ, USA., Mouawad C; MRL, Medical Affairs, Merck & Co., Inc, Rahway, NJ, USA., Palmu AA; FVR - Finnish Vaccine Research, Tampere, Finland., Platt H; MRL, Clinical Research, Merck & Co., Inc, Rahway, NJ, USA., Johnson KD; MRL, Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA., McIntosh ED; MRL, Scientific Affairs, MSD (UK) Limited, London, UK., Abadi J; MRL, Medical Affairs, Merck & Co., Inc, Rahway, NJ, USA., Buchwald UK; MRL, Clinical Research, Merck & Co., Inc, Rahway, NJ, USA., Feemster K; MRL, Medical Affairs, Merck & Co., Inc, Rahway, NJ, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2024 Oct 22. Date of Electronic Publication: 2024 Oct 22.
Autor:
Merdrignac L; Epidemiology Department, Epiconcept, Paris, France. Electronic address: l.merdrignac@epiconcept.fr., Aït El Belghiti F; Direction des maladies infectieuses, Santé Publique France, Paris, France., Pandolfi E; Preventive and Predictive Medicine Research Unit, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy., Acosta L; Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain; Departament d'Estadística i Investigació Operativa, Universitat Politècnica de Catalunya- BarcelonaTech (UPC), Barcelona, Spain., Fabiánová K; National Institute of Public Health, Prague, Czech Republic., Habington A; Children's Health Ireland, Crumlin, Dublin, Ireland., García Cenoz M; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain., Bøås H; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222, Skøyen, 0213 Oslo, Norway., Toubiana J; Biodiversité et Epidémiologie des bactéries et pathogènes, Institut Pasteur, Paris, France; National Reference Center for Whooping Cough and Other Bordetella Infections, Institut Pasteur, Paris, France., Tozzi AE; Preventive and Predictive Medicine Research Unit, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy., Jordan I; Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; University of Barcelona, Barcelona, Spain., Zavadilová J; National Institute of Public Health, Prague, Czech Republic., O'Sullivan N; Children's Health Ireland, Crumlin, Dublin, Ireland., Navascués A; Hospital Universitario Navarra, Pamplona., Flem E; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222, Skøyen, 0213 Oslo, Norway., Croci I; Preventive and Predictive Medicine Research Unit, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy., Jané M; Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; University of Barcelona, Barcelona, Spain., Křížová P; National Institute of Public Health, Prague, Czech Republic., Cotter S; Health Protection Surveillance Centre, Dublin, Ireland., Fernandino L; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain., Bekkevold T; Division of Infection Control, Norwegian Institute of Public Health, P.O. Box 222, Skøyen, 0213 Oslo, Norway., Muñoz-Almagro C; Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; Medicine Department, Universitat Internacional de Catalunya, Barcelona, Spain., Bacci S; European Centre for Diseases Control and Prevention, Stockholm, Sweden., Kramarz P; European Centre for Diseases Control and Prevention, Stockholm, Sweden., Kissling E; Epidemiology Department, Epiconcept, Paris, France., Savulescu C; Epidemiology Department, Epiconcept, Paris, France.
Publikováno v:
Vaccine [Vaccine] 2024 Apr 02; Vol. 42 (9), pp. 2370-2379. Date of Electronic Publication: 2024 Mar 11.
Autor:
Bøås H; Norwegian Institute of Public Health, Oslo, Norway., Havdal LB; Norwegian Institute of Public Health, Oslo, Norway.; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway., Størdal K; Department of Pediatrics, Østfold Hospital, Grålum, Norway.; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Døllner H; Department of Pediatrics, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Leegaard TM; Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.; Division of Medicine and Laboratory Sciences, Institute of Clinical Medicine - Campus Ahus, University of Oslo, Oslo, Norway., Bekkevold T; Norwegian Institute of Public Health, Oslo, Norway., Flem E; Norwegian Institute of Public Health, Oslo, Norway., Inchley C; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway., Nordbø SA; Department of Medical Microbiology, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Rojahn AE; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Debes S; Department of Medical Microbiology, Østfold Hospital, Grålum, Norway., Barstad B; Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway., Haarr E; Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway., Kran AB; Norwegian Institute of Public Health, Oslo, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
PloS one [PLoS One] 2024 Mar 11; Vol. 19 (3), pp. e0298104. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
Autor:
Mohanty S; Outcomes Research, Merck & Co, Inc, Rahway, NJ, USA., Tsai JH; Evidence & Access, OPEN Health, Bethesda, MD, USA., Ning N; Evidence & Access, OPEN Health, Newton, MA, USA., Martinez A; Evidence & Access, OPEN Health, Bethesda, MD, USA., Verma RP; Evidence & Access, OPEN Health, Bethesda, MD, USA., Chun B; Global Medical & Value Capabilities Merck & Co, Inc, Rahway, NJ, USA., Johnson KD; Outcomes Research, Merck & Co, Inc, Rahway, NJ, USA., Cossrow N; Outcomes Research, Merck & Co, Inc, Rahway, NJ, USA., Bailey MD; Outcomes Research, Merck & Co, Inc, Rahway, NJ, USA., Weiss T; Outcomes Research, Merck & Co, Inc, Rahway, NJ, USA., Flem E; Global and Medical Scientific Affairs, Merck & Co, Inc, Rahway, NJ, USA., Schmier JK; Evidence & Access, OPEN Health, Bethesda, MD, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 966-973. Date of Electronic Publication: 2024 Oct 18.
Autor:
Gibory M; Department of Microbiology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway., Bruun T; Department of Infection Epidemiology and Modeling, Norwegian Institute of Public Health, Oslo, Norway., Flem E; Department of Infection Epidemiology and Modeling, Norwegian Institute of Public Health, Oslo, Norway., Dembinski JL; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway., Haltbakk I; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway., Størdal K; Department of Pediatrics, Østfold Hospital Trust, Fredrikstad, Norway., Nordbø SA; Department of Medical Microbiology, St. Olavs Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Jakobsen K; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Haarr E; Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway., Leegaard TM; Department of Microbiology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Microbiology and Infection Control, Akershus University Hospital, Nordbyhagen, Norway., Dudman SG; Department of Microbiology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Journal of medical virology [J Med Virol] 2022 Jun; Vol. 94 (6), pp. 2624-2631. Date of Electronic Publication: 2021 Dec 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Havdal LB; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Postboks 1000, 1478, Lørenskog, Norway; Norwegian Institute of Public Health, PO BOX 222 Skøyen, 0213, Oslo, Norway; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: l.b.havdal@medisin.uio.no., Bøås H; Norwegian Institute of Public Health, PO BOX 222 Skøyen, 0213, Oslo, Norway., Bekkevold T; Norwegian Institute of Public Health, PO BOX 222 Skøyen, 0213, Oslo, Norway., Kran AB; Norwegian Institute of Public Health, PO BOX 222 Skøyen, 0213, Oslo, Norway; Department of Microbiology, Oslo University Hospital, Ullevål, Postboks 4950 Nydalen, 0424, Oslo, Norway., Rojahn AE; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Ullevål, Postboks, 4950 Nydalen, 0424, Oslo, Norway., Størdal K; Department of Paediatrics, Østfold Hospital, Kalnes, Postboks 300, 1714, Grålum, Norway; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Debes S; Department of Medical Microbiology, Østfold Hospital, Kalnes, Postboks 300, 1714, Grålum, Norway., Døllner H; Department of Paediatrics, St. Olavs University Hospital, Postboks 3250 Torgarden, 7006, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Norway., Nordbø SA; Department of Medical Microbiology, St. Olavs University Hospital, Postboks 3250 Torgarden, 7006, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Norway., Barstad B; Department of Paediatric and adolescent Medicine, Stavanger University Hospital, Postboks 8100, 4068, Stavanger, Norway., Haarr E; Department of Medical Microbiology, Stavanger University Hospital, Postboks 8100, 4068, Stavanger, Norway., Fernández LV; Norwegian Institute of Public Health, PO BOX 222 Skøyen, 0213, Oslo, Norway., Nakstad B; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Postboks 1000, 1478, Lørenskog, Norway; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Inchley C; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Postboks 1000, 1478, Lørenskog, Norway., Flem E; Norwegian Institute of Public Health, PO BOX 222 Skøyen, 0213, Oslo, Norway.
Publikováno v:
The Journal of infection [J Infect] 2023 Apr; Vol. 86 (4), pp. 420. Date of Electronic Publication: 2022 Dec 24.
Autor:
Merdrignac L, Aït El Belghiti F, Pandolfi E, Jané M, Murphy J, Fabiánová K, García Cenoz M, Flem E, Guillot S, Tozzi AE, Carmona G, Habington A, Zavadilová J, Navasués A, Bøås H, Lévy-Brühl D, Ferretti B, Miguel Lanaspa Pérez, O'Sullivan N, Krížová P, Fernandino L, Bekkevold T, Hanslik T, Munoz-Almagro C, Bacci S, Spiteri G, Valenciano M, Moren A, PERTINENT Group, PERTINENT group
Publikováno v:
EUROSURVEILLANCE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Universidad de las Islas Baleares
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Universidad de las Islas Baleares
IntroductionPERTINENT is a pilot active surveillance system of infants hospitalised with pertussis in six European Union/European Economic Area countries (37 hospitals, seven sites).AimThis observational study aimed to estimate annual pertussis incid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4a8170d258236a52c77e9e120f23b991
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18831
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18831
Autor:
Bøås H; Norwegian Institute of Public Health, Oslo, Norway., Bekkevold T; Norwegian Institute of Public Health, Oslo, Norway., Havdal LB; Norwegian Institute of Public Health, Oslo, Norway.; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Nordbyhagen, Norway., Kran AB; Norwegian Institute of Public Health, Oslo, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Rojahn AE; Department of Paediatrics, Oslo University Hospital, Oslo, Norway., Størdal K; Department of Paediatrics, Oslo University Hospital, Oslo, Norway.; Department of Pediatrics, Østfold Hospital, Grålum, Norway.; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Debes S; Department of Medical Microbiology, Østfold Hospital, Grålum, Norway., Døllner H; Department of Pediatrics, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Nordbø SA; Department of Medical Microbiology, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Barstad B; Department of Paediatric and Adolescent Medicine, Stavanger University Hospital, Stavanger, Norway., Haarr E; Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway., Vázquez Fernández L; Norwegian Institute of Public Health, Oslo, Norway., Nakstad B; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Nordbyhagen, Norway.; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Leegaard TM; Department of Microbiology and Infection Control, Akershus University Hospital, Nordbyhagen, Norway.; Division of Medicine and Laboratory Sciences, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hungnes O; Norwegian Institute of Public Health, Oslo, Norway., Flem E; Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
Frontiers in pediatrics [Front Pediatr] 2022 Sep 07; Vol. 10, pp. 963274. Date of Electronic Publication: 2022 Sep 07 (Print Publication: 2022).
Autor:
Havdal LB; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway.; Norwegian Institute of Public Health, Oslo, Norway., Bøås H; Norwegian Institute of Public Health, Oslo, Norway., Bekkevold T; Norwegian Institute of Public Health, Oslo, Norway., Bakken Kran AM; Norwegian Institute of Public Health, Oslo, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Rojahn AE; Division of Paediatric and Adolescent Medicine, Oslo University Hospital Ullevål, Oslo, Norway., Størdal K; Department of Paediatrics, Østfold Hospital Kalnes, Grålum, Norway.; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Debes S; Department of Medical Microbiology, Østfold Hospital Kalnes, Grålum, Norway., Døllner H; Department of Paediatrics, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Nordbø SA; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Medical Microbiology, St. Olavs University Hospital, Trondheim, Norway., Barstad B; Department of Paediatric and Adolescent Medicine, Stavanger University Hospital, Stavanger, Norway., Haarr E; Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway., Fernández LV; Norwegian Institute of Public Health, Oslo, Norway., Nakstad B; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway.; Division of Paediatric and Adolescent Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Inchley C; Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway., Flem E; Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
Frontiers in pediatrics [Front Pediatr] 2022 Aug 30; Vol. 10, pp. 1004739. Date of Electronic Publication: 2022 Aug 30 (Print Publication: 2022).